SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Charles W. Popper, Mood Disorders in Youth, Child and Adolescent Psychiatric Clinics of North America, 2013, 22, 3, 403

    CrossRef

  2. 2
    Peter B. Bongiorno, Michael T. Murray, Textbook of Natural Medicine, 2013,

    CrossRef

  3. 3
    Kelly Shaw, Jane Turner, Christopher Del Mar, Are tryptophan and 5-hydroxytryptophan effective treatments for depression? A meta-analysis, Australian and New Zealand Journal of Psychiatry, 2002, 36, 4
  4. 4
    Michael E. Thase, A. John Rush, Siegfried Kasper, Charles B. Nemeroff, Tricyclics and newer antidepressant medications: Treatment options for treatment-resistant depressions, Depression, 1994, 2, 3
  5. 5
    Jan Scott, Andrew Cole, Donald Eccleston, Dealing with persisting abnormalities of mood, International Review of Psychiatry, 1991, 3, 1, 19

    CrossRef

  6. 6
    Kerrin White, George Simpson, Treatment-Resistant Depression, Psychiatric Annals, 1987, 17, 4, 274

    CrossRef

  7. You have free access to this content7
    Timothy D. Brewerton, Margaret M. Heffernan, Norman E. Rosenthal, PSYCHIATRIC ASPECTS OF THE RELATIONSHIP BETWEEN EATING AND MOOD, Nutrition Reviews, 1986, 44,
  8. You have free access to this content8
    Simon N. Young, THE EFFECT ON AGGRESSION AND MOOD OF ALTERING TRYPTOPHAN LEVELS, Nutrition Reviews, 1986, 44,
  9. 9
    Svend E. Møller, Tryptophan to competing amino acids ratio in depressive disorder: relation to efficacy of antidepressive treatments, Acta Psychiatrica Scandinavica, 1985, 72,
  10. 10
    David A. Bender, Biochemistry of tryptophan in health and disease, Molecular Aspects of Medicine, 1983, 6, 2, 101

    CrossRef

  11. 11
    William P. Leighton, Seymour Rosenblatt, J.D. Chanley, Lithium-induced changes in plasma amino acid levels during treatment of affective disorders, Psychiatry Research, 1983, 8, 1, 33

    CrossRef

  12. 12
    Svend E. Møller, Per Honoré, Ole B. Larsen, Tryptophan and tyrosine ratios to neutral amino acids in endogenous depression, Journal of Affective Disorders, 1983, 5, 1, 67

    CrossRef

  13. 13
    J. S. Kim, W. Schmid-Burgk, D. Claus, H. H. Kornhuber, Increased serum glutamate in depressed patients, Archiv f�r Psychiatrie und Nervenkrankheiten, 1982, 232, 4, 299

    CrossRef

  14. 14
    J. Wålinder, A. Carlsson, R. Persson, 5-HT reuptake inhibitors plus tryptophan in endogenous depression, Acta Psychiatrica Scandinavica, 1981, 63,
  15. 15
    Carolyn H. Asbury, Medical Drugs of Limited Commercial Interest: Profit Alone is a Bitter Pill, International Journal of Health Services, 1981, 11, 3, 451

    CrossRef

  16. 16
    E. Martin G�l, Arnold D. Sherman, l-Kynurenine Its synthesis and possible regulatory function in brain, Neurochemical Research, 1980, 5, 3, 223

    CrossRef

  17. 17
    AR Green, JK Aronson, G Curzon, HF Woods, Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan., British Journal of Clinical Pharmacology, 1980, 10, 6
  18. 18
    S.E. Møller, L. Kirk, P. Honoré, Relationship between plasma ratio of tryptophan to competing amino acids and the response to L-tryptophan treatment in endogenously depressed patients, Journal of Affective Disorders, 1980, 2, 1, 47

    CrossRef

  19. 19
    S.E. Møller, L. Kirk, P. Honoré, Free and total plasma tryptophan in endogenous depression, Journal of Affective Disorders, 1979, 1, 1, 69

    CrossRef

  20. 20
    Roger M. Pinder, Annual Reports in Medicinal Chemistry Volume 14, 1979,

    CrossRef

  21. 21
    Kelly A Shaw, Jane Turner, Chris Del Mar, Tryptophan and 5-Hydroxytryptophan for depression, The Cochrane Library,